The common cold: Effects of intranasal fluticasone propionate treatment

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 6 II, 1998, Pages 726-731

  Puhakka, Tuomo ^a,d   Mäkelä, Mika J ^a   Malmström, Kristiina ^a   Uhari, Matti ^b   Savolainen, Johannes ^a   Terho, Erkki O ^a   Pulkkinen, Markku ^c   Ruuskanen, Olli ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c GlaxoWellcome Ltd

^d Department of Pediatrics   (Finland)

Author keywords

Cold; Common cold; Fluticasone propionate; Rhinovirus; Viral respiratory infection

Indexed keywords

FLUTICASONE PROPIONATE;

ADULT; ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; NOSE CONGESTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOVIRUS; SORE THROAT; STREPTOCOCCUS PNEUMONIAE; SYMPTOMATOLOGY; VIRUS SHEDDING;

EID: 0031815075     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(98)70301-x     Document Type: Article

References (18)

1. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119:1198-208.
2. Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993;48:476-90.
3. Klassen TP. Recent advances in the treatment of bronchiolitis and laryngitis. Pediatr Clin North Am 1997;44:249-61.
4. McGowan JEJ, Chesney PJ, Crossley KB, LaForce FM. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. J Infect Dis 1992;165:1-13.
5. Hyypiä T, Auvinen P, Maaronen M. Polymerase chain reaction for human picornaviruses. J Gen Virol 1989;70:3261-8.
6. Arola A, Santti J, Halonen P, Ruuskanen O, Hyypiä T. Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J Clin Microbiol 1996;34:313-8.
7. Hughes PJ, North C, Jellis CH, Minor PD, Stanway G. The nucleotide sequence of human rhinovirus IB: molecular relationships within the rhinovirus genus. J Gen Virol 1988;69:49-58.
8. Olive DM, Al Mufti S, Al Mulla W. Detection and differentiation of picornaviruses in clinical samples following genomic amplification. J Gen Virol 1990;71:2141-7.
9. Halonen P, Rocha E, Hierholzer J. Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization. J Clin Microbiol 1995;33:648-53.
10. Mäkelä MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 1998;36:539-42.
11. Sperber SJ, Hayden FG. Chemotherapy of rhinovirus colds. Anti-microb Agents Chemother 1988;32:409-19.
12. Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol 1997;78:531-9.
13. Farr BM, Gwaltney JM Jr, Hendley JO, Hayden FG, Naclerio RM, McBride T, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990;162:1173-7.
14. Gustafson LM, Proud D, Hendley JO, Hayden FG, Gwaltney JM. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996;97:1009-14.
15. Clementsen P, Pedersen M, Permin H, Espersen F, Norn S. Influenza A virus potentiates bacteria-induced histamine release. Examination of normal individuals and patients allergic to bacteria. Allergy 1990;45:464-70.
16. Tashiro M, Ciborowski P, Reinacher M, Pulverer G, Klenk HD, Rott R. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology 1987;157:421-30.
17. Kaiser L, Lew D, Hirschel B, Auckenthaler R, Morabia A, Heald A, et al. Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996;347:1507-10.
18. Hayden FG, Hipskind GJ, Woerner DH, Eisen GF, Janssens M, Janssen PA, et al. Intranasal pirodavir (R77,975) treatment of rhinovirus colds. Antimicrob Agents Chemother 1995;39:290-4.